IRCT20210524051384N6 IRCT 2021-11-14 Rasht University of Medical Sciences Triamcinolone and Verapamil injection on Keloid scars Evaluation of the combined effect of intralesional injection of Triamcinolone and Verapamil in the treatment of post-surgery Keloid scars 2021-11-22 anticipated 16 Complete https://irct.ir/trial/58403 interventional Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: In this study, limited randomization will be used as a block randomization method to design patients into intervention and control groups. The latest allocation will prevent the direction from being detected in the blocks under consideration; the size of the blocks is considered random, with 2 or 4 It will use R software to generate random numbers using the Runif command. 3 Surgical keloid lesion. Intervention 1: Intervention group: patients which are candidate of receiving triamcinolone (without verapamil), Injections into scars with Insulin gauge syringe No. 24 without local anesthesia and intralesional injection of triamcinolone acetonide (Caspian khazar Triam Company) at a concentration of 40 mg / ml and a maximum dose of 2 mg per scar per session are performed. Intervention 2: Group receiving triamcinolone and verapamil (group 2) Scar injections with insulin gauge syringe number 24 without local anesthesia and intralesional injection of verapamil (myland verapamil) 2.5 mg / ml with a maximum dose of 2.5 mg and triamcinolone At a concentration of 40 mg / ml and a maximum dose of 2 mg per scar per session. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is I haven't decided yet - the release schedule is still unknown